428 related articles for article (PubMed ID: 27183630)
1. ERβ in CD4+ T Cells Is Crucial for Ligand-Mediated Suppression of Central Nervous System Autoimmunity.
Aggelakopoulou M; Kourepini E; Paschalidis N; Panoutsakopoulou V
J Immunol; 2016 Jun; 196(12):4947-56. PubMed ID: 27183630
[TBL] [Abstract][Full Text] [Related]
2. ERβ-Dependent Direct Suppression of Human and Murine Th17 Cells and Treatment of Established Central Nervous System Autoimmunity by a Neurosteroid.
Aggelakopoulou M; Kourepini E; Paschalidis N; Simoes DC; Kalavrizioti D; Dimisianos N; Papathanasopoulos P; Mouzaki A; Panoutsakopoulou V
J Immunol; 2016 Oct; 197(7):2598-609. PubMed ID: 27549171
[TBL] [Abstract][Full Text] [Related]
3. Indoles mitigate the development of experimental autoimmune encephalomyelitis by induction of reciprocal differentiation of regulatory T cells and Th17 cells.
Rouse M; Singh NP; Nagarkatti PS; Nagarkatti M
Br J Pharmacol; 2013 Jul; 169(6):1305-21. PubMed ID: 23586923
[TBL] [Abstract][Full Text] [Related]
4. PDCD5 negatively regulates autoimmunity by upregulating FOXP3(+) regulatory T cells and suppressing Th17 and Th1 responses.
Xiao J; Liu C; Li G; Peng S; Hu J; Qu L; Lv P; Zhang Y; Ma D; Chen Y
J Autoimmun; 2013 Dec; 47():34-44. PubMed ID: 24012345
[TBL] [Abstract][Full Text] [Related]
5. An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.
Choi JH; Lee MJ; Jang M; Kim EJ; Shim I; Kim HJ; Lee S; Lee SW; Kim YO; Cho IH
PLoS One; 2015; 10(10):e0138592. PubMed ID: 26444423
[TBL] [Abstract][Full Text] [Related]
6. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP
Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850
[TBL] [Abstract][Full Text] [Related]
7. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
[TBL] [Abstract][Full Text] [Related]
8. Bacillus-derived poly-γ-glutamic acid reciprocally regulates the differentiation of T helper 17 and regulatory T cells and attenuates experimental autoimmune encephalomyelitis.
Lee K; Hwang S; Paik DJ; Kim WK; Kim JM; Youn J
Clin Exp Immunol; 2012 Oct; 170(1):66-76. PubMed ID: 22943202
[TBL] [Abstract][Full Text] [Related]
9. Estrogen Signaling in Bystander Foxp3
Garnier L; Laffont S; Lélu K; Yogev N; Waisman A; Guéry JC
J Immunol; 2018 Dec; 201(11):3218-3228. PubMed ID: 30355786
[TBL] [Abstract][Full Text] [Related]
10. Age-associated changes in rat immune system: lessons learned from experimental autoimmune encephalomyelitis.
Djikić J; Nacka-Aleksić M; Pilipović I; Stojić-Vukanić Z; Bufan B; Kosec D; Dimitrijević M; Leposavić G
Exp Gerontol; 2014 Oct; 58():179-97. PubMed ID: 25128713
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH
J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181
[TBL] [Abstract][Full Text] [Related]
12. Eomesodermin Expression in CD4+ T Cells Restricts Peripheral Foxp3 Induction.
Lupar E; Brack M; Garnier L; Laffont S; Rauch KS; Schachtrup K; Arnold SJ; Guéry JC; Izcue A
J Immunol; 2015 Nov; 195(10):4742-52. PubMed ID: 26453746
[TBL] [Abstract][Full Text] [Related]
13. Melatonin enhances interleukin-10 expression and suppresses chemotaxis to inhibit inflammation in situ and reduce the severity of experimental autoimmune encephalomyelitis.
Chen SJ; Huang SH; Chen JW; Wang KC; Yang YR; Liu PF; Lin GJ; Sytwu HK
Int Immunopharmacol; 2016 Feb; 31():169-77. PubMed ID: 26735612
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs targeting TGF-β signaling exacerbate central nervous system autoimmunity by disrupting regulatory T cell development and function.
Rau CN; Severin ME; Lee PW; Deffenbaugh JL; Liu Y; Murphy SP; Petersen-Cherubini CL; Lovett-Racke AE
Eur J Immunol; 2024 Jun; 54(6):e2350548. PubMed ID: 38634287
[TBL] [Abstract][Full Text] [Related]
15. Targeting pre-ligand assembly domain of TNFR1 ameliorates autoimmune diseases - an unrevealed role in downregulation of Th17 cells.
Wang YL; Chou FC; Chen SJ; Lin SH; Chang DM; Sytwu HK
J Autoimmun; 2011 Nov; 37(3):160-70. PubMed ID: 21689905
[TBL] [Abstract][Full Text] [Related]
16. Activation of aryl hydrocarbon receptor signaling by a novel agonist ameliorates autoimmune encephalomyelitis.
Abdullah A; Maged M; Hairul-Islam M I; Osama I A; Maha H; Manal A; Hamza H
PLoS One; 2019; 14(4):e0215981. PubMed ID: 31026283
[TBL] [Abstract][Full Text] [Related]
17. Th17 Cells and autoimmune encephalomyelitis (EAE/MS).
Aranami T; Yamamura T
Allergol Int; 2008 Jun; 57(2):115-20. PubMed ID: 18427164
[TBL] [Abstract][Full Text] [Related]
18. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
[TBL] [Abstract][Full Text] [Related]
19. Intravenous gammaglobulin inhibits encephalitogenic potential of pathogenic T cells and interferes with their trafficking to the central nervous system, implicating sphingosine-1 phosphate receptor 1-mammalian target of rapamycin axis.
Othy S; Hegde P; Topçu S; Sharma M; Maddur MS; Lacroix-Desmazes S; Bayry J; Kaveri SV
J Immunol; 2013 May; 190(9):4535-41. PubMed ID: 23526819
[TBL] [Abstract][Full Text] [Related]
20. Cyclic AMP Pathway Suppress Autoimmune Neuroinflammation by Inhibiting Functions of Encephalitogenic CD4 T Cells and Enhancing M2 Macrophage Polarization at the Site of Inflammation.
Veremeyko T; Yung AWY; Dukhinova M; Kuznetsova IS; Pomytkin I; Lyundup A; Strekalova T; Barteneva NS; Ponomarev ED
Front Immunol; 2018; 9():50. PubMed ID: 29422898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
